CPX
IDYA icon

Canaan Partners X’s IDEAYA Biosciences IDYA Stock Holding History

Canaan Partners X’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$71.8M Hold
2,660,713
– – 96.06% 1
2023
Q2 		$62.5M Hold
2,660,713
– – 74.33% 1
2023
Q1 		$36.5M Hold
2,660,713
– – 65.16% 1
2022
Q4 		$48.3M Hold
2,660,713
– – 84.97% 1
2022
Q3 		$39.7M Hold
2,660,713
– – 62.26% 1
2022
Q2 		$36.7M Hold
2,660,713
– – 63.52% 1
2022
Q1 		$29.8M Hold
2,660,713
– – 30.23% 2
2021
Q4 		$62.9M Hold
2,660,713
– – 24.52% 3
2021
Q3 		$67.8M Hold
2,660,713
– – 19.31% 3
2021
Q2 		$55.8M Hold
2,660,713
– – 83.88% 1
2021
Q1 		$62.5M Hold
2,660,713
– – 85.23% 1
2020
Q4 		$37.3M Hold
2,660,713
– – 77.44% 1
2020
Q3 		$33.4M Hold
2,660,713
– – 66.44% 1
2020
Q2 		$37.8M Hold
2,660,713
– – 45.36% 2
2020
Q1 		$11M Hold
2,660,713
– – 12.07% 2
2019
Q4 		$20M Buy
+2,660,713
New +$19M 12.9% 2

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canaan Partners X's IDYA Position: Q3 2023 in Review

Canaan Partners X held its IDEAYA Biosciences (IDYA) position steady in Q3 2023 at 2,660,713 shares worth $71.8M. The position accounts for 96.06% of the portfolio, ranked #1.

Canaan Partners X first reported a position in IDYA in Q4 2019 and has held it in 16 quarters since. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

  • Canaan Partners X held 2,660,713 shares of IDEAYA Biosciences worth $71.8M as of Q3 2023.
  • Canaan Partners X left its IDEAYA Biosciences share count unchanged in Q3 2023.
  • IDEAYA Biosciences made up 96.06% of Canaan Partners X's portfolio in Q3 2023, its #1 holding.
  • Canaan Partners X first reported a position in IDEAYA Biosciences in Q4 2019 and has held it in 16 quarters since.
  • 144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Canaan Partners X's 13F filing for Q3 2023, filed 11 Oct 2023.